IP Library Granted Patent US 8,242,083
Granted Patent B2
US 8,242,083 · App. 12/490,031 · Granted Aug 14, 2012

Kinase substrates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,242,083
App. No.
12/490,031
Granted
Aug 14, 2012
Kind
B2
Abstract

Tyrosine kinase substrates are described herein that are phosphorylated by many and diverse tyrosine kinases, and are chemically stable relative to co-polymers of poly-EY or poly-EAY having random molecular weights in the range of 20-50 kDa. Tyrosine kinase substrate peptides are provided according to embodiments described herein which include an isolated tyrosine kinase substrate peptide having molecular weight in the range of about 0.5 kD-10 kD. Tyrosine kinase substrate peptides are provided according to embodiments described herein having no more than 50 amino acids. The peptides include 2-25 phosphorylation modules and each phosphorylation module has 2-3 amino acid residues.

Claims (18)

1. An isolated tyrosine kinase substrate peptide, comprising:

an amino acid sequence selected from the group consisting of: AYE AYE AYE K EYA EYA EYA K AYA EYE (SEQ ID NO. 1); AYE AYE AYE AYA EYE (SEQ ID NO.2); C AYE AYE AYE K EYA EYA EYA K AYA EYE R (SEQ ID NO. 3); CGG E AYE AYE AYE AYA EYE ARR (SEQ ID NO.4); and AYE AYE AYE B EYA EYA EYA B AYA EYE (SEQ ID NO. 5), where each B is a basic amino acid residue independently selected from histidine, lysine and arginine.

2. The tyrosine kinase substrate peptide of claim 1 , wherein the peptide comprises at least one basic amino acid residue.

3. The tyrosine kinase substrate peptide of claim 2 , the at least one basic amino acid residue is selected from the group consisting of: histidine, lysine and arginine.

4. The tyrosine kinase substrate peptide of claim 1 , wherein the peptide has a net positive charge.

5. The tyrosine kinase substrate peptide of claim 1 , wherein the peptide comprises a detectable label.

6. The tyrosine kinase substrate peptide of claim 1 , wherein the detectable label is a FRET acceptor.

7. A plurality of tyrosine kinase substrate peptides, each peptide of the plurality comprising:

an amino acid sequence selected from the group consisting of: AYE AYE AYE K EYA EYA EYA K AYA EYE (SEQ ID NO. 1); AYE AYE AYE AYA EYE (SEQ ID NO.2); C AYE AYE AYE K EYA EYA EYA K AYA EYE R (SEQ ID NO. 3); CGG E AYE AYE AYE AYA EYE ARR (SEQ ID NO.4) and AYE AYE AYE B EYA EYA EYA B AYA EYE (SEQ ID NO. 5), where each B is a basic amino acid residue independently selected from histidine, lysine and arginine.

8. The plurality of tyrosine kinase substrate peptides of claim 7 , wherein each peptide has a net positive charge.

9. A kit for detection of tyrosine kinase activity, comprising:

a tyrosine kinase substrate peptide wherein the tyrosine kinase substrate peptide comprises an amino acid sequence selected from the group consisting of: AYE AYE AYE K EYA EYA EYA K AYA EYE (SEQ ID NO. 1); AYE AYE AYE AYA EYE (SEQ ID NO.2); C AYE AYE AYE K EYA EYA EYA K AYA EYE R (SEQ ID NO. 3); CGG E AYE AYE AYE AYA EYE ARR (SEQ ID NO.4) and AYE AYE AYE B EYA EYA EYA B AYA EYE (SEQ ID NO. 5), where each B is a basic amino acid residue independently selected from histidine, lysine and arginine.

10. The kit for detection of tyrosine kinase activity of claim 9 , wherein the peptide comprises a detectable label.

11. The kit for detection of tyrosine kinase activity of claim 10 , wherein the detectable label is a FRET acceptor.

12. The kit for detection of tyrosine kinase activity of claim 10 , wherein the N-terminus of the peptide comprises the detectable label.

13. The kit for detection of tyrosine kinase activity of claim 9 , wherein the peptide comprises at least one basic amino acid residue.

14. The kit for detection of tyrosine kinase activity of claim 13 , the at least one basic amino acid residue is selected from the group consisting of: histidine, lysine and arginine.

15. The kit for detection of tyrosine kinase activity of claim 9 , wherein the peptide has a net positive charge.

Assignments (2)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 066881/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2009
From: BEAUDET, LUCILLE; ROBY, PHILIPPE; BLOUIN, JULIE
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 022881/0486 →